16. CLINICAL, PARACLINICAL CHARACTERISTICS AND TREATMENT OF BOZDERLINE OVARIAN TUMORS AT NATIONAL HOSPITAL OF OBSTETRICS & GYNECOLOGY

Ngo Vuong Minh1, Do Xuan Vinh2, Le Duy Toan2, Nguyen Quoc Tuan1
1 Hanoi Medical University
2 Hanoi Obstretics & Gynecology Hospital

Main Article Content

Abstract

Objectives: Describe clinical, paraclinical features and treatment results of borderline ovarian tumors at the National Hospital of Obstetrics and Gynecology.


Materials and research methods: Sample size: 88 patients during 5 years from January 1, 2018 to December 31, 2022. Methods: Retrospective descriptive study.


Results: The proportion of serous, mucinous and other types of tumors was 50%, 38% and 12% respectively. The average age was 36.07, the 30 - 39 year old group accounted for the highest proportion. Lower abdominal pain was the most common symptom (43.2%). Most ovarian tumors were borderline on one side, painless and movable. 54,5% tumors > 10 cm and the size of mucinous tumors was statistically significantly larger than that of serous tumors. On ultrasound, the rate of septa was 47.7%, papillae was 35.2%, solid tissue was 35.2%, and mixed sound was 60.2%. The abnormal CA -125 value was 56.8%, decreasing rapidly after surgery and chemotherapy. The rate of conservative surgery was 77.2%, of radical surgery was 21.8% and of second surgery was 11.3%.


Conclusion: Boderline ovarian tumors may have some malignant characteristics. Surgery is an effective treatment method and conservative surgery is increasingly widely applied.

Article Details

References

[1] Priya C, Sunesh K, L Alit Kumar, Borderline
ovarian tumors: an update, Indian Journal of
Medical & PA Ediatric Oncology, 29: p.2, 2008.
[2] Skírnisdóttir I, Garmo H, Wilander E et al.,127
Borderline ovarian tumors in Sweden 1960-
2005: “Trends in incidence and age at diagnosis
compared to ovarian cancer; International
Journal of Cancer, 123(8), 1897–1901, 2008.
[3] Williams G, Epithelial ovarian cancer, Copyright
The Mcgraw – Hill Companies, Chapter 35, pp:
1 – 10, 2006.
[4] Nguyễn Thị Hương Linh, Nghiên cứu đặc điểm
lâm sàng, cận lâm sàng và xử trí u buồng trứng
giáp biên tại Bệnh viện Phụ sản Trung ương,
Luận văn tốt nghiệp Bác sĩ chuyên khoa cấp II,
Đại học Y Hà Nội, 2010.
[5] Eltabbakh GH, Natarajan N, Piver MS et al.,
Epidemiologic Differences between Women
with Borderline Ovarian Tumors and Women
with Epithelial Ovarian Cancer. Gynecologic
Oncology, 74(1), 103–107, 1999.
[6] Nguyễn Duy Tuấn, Nhận xét một số đặc điểm
lâm sàng, cận lâm sàng và kết quả điều trị u
buồng trứng thể giáp biên tại Bệnh viện K, Luận
văn tốt nghiệp Thạc sỹ y học, Đại học Y Hà Nội,
2013.
[7] Nguyễn Thị Nga, Nghiên cứu đặc điểm lâm sàng
cận lâm sàng và xử trí u nhầy buồng trứng tại
Bệnh viện Phụ sản trung ương, Luận văn bác sỹ
chuyên khoa cấp II, Đại học Y Hà Nội, 2021.
[8] Borderline ovarian tumors: French guidelines
from the CNGOF, Journal of Gynecology
Obstetrics and Human Reproduction, 2021.